IL6 and neoplasm: Once in contact with OS cells, MSCs trans-differentiate into cancer-associated fibroblasts, which, in turn, release cytokines such as IL-6 and IL-8 in the tumor microenvironment, which promote OS cell motility, invasiveness, and trans-endothelial migration [55].